John T. Henderson - Apr 15, 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Henderson
Stock symbol
CYTK
Transactions as of
Apr 15, 2025
Transactions value $
$875
Form type
4
Date filed
4/16/2025, 04:25 PM
Previous filing
Jan 6, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $124K +20K +40.37% $6.21 69.5K Apr 15, 2025 Direct
transaction CYTK Common Stock Sale -$123K -3.19K -4.59% $38.66 66.3K Apr 15, 2025 Direct
holding CYTK Common Stock 83 Apr 15, 2025 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Stock Option (Right to Buy) Options Exercise $0 -20K -100% $0.00 0 Apr 15, 2025 Common Stock 20K $6.21 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).